Cutler Group LP Krystal Biotech, Inc. Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	SELL	$48.93 - $73.47 $14,679 - $22,041	-300 Reduced 42.86%	400 $20,000
Q1 2022 Apr 14, 2022	SELL	$51.99 - $72.11 $1.89 Million - $2.62 Million	-36,300 Reduced 98.11%	700 $21,000
Q4 2021 Jan 18, 2022	BUY	$39.81 - $88.24 $1.01 Million - $2.24 Million	25,400 Added 218.97%	37,000 $140,000
Q3 2021 Oct 26, 2021	BUY	$52.01 - $71.77 $603,316 - $832,532	11,600 New	11,600 $295,000

310

24.4M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.89B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.